These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 25752711)

  • 21. Nanomaterial applications in multiple sclerosis inflamed brain.
    Ballerini C; Baldi G; Aldinucci A; Maggi P
    J Neuroimmune Pharmacol; 2015 Mar; 10(1):1-13. PubMed ID: 25616566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanotechnology and human health: risks and benefits.
    Cattaneo AG; Gornati R; Sabbioni E; Chiriva-Internati M; Cobos E; Jenkins MR; Bernardini G
    J Appl Toxicol; 2010 Nov; 30(8):730-44. PubMed ID: 21117037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liposomal nanomedicines.
    Fenske DB; Cullis PR
    Expert Opin Drug Deliv; 2008 Jan; 5(1):25-44. PubMed ID: 18095927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular biology: applications in hepato-gastroenterology].
    Blum HE
    Leber Magen Darm; 1993 Jul; 23(4):144-6, 149. PubMed ID: 8366750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomedical nanomaterials for imaging-guided cancer therapy.
    Huang Y; He S; Cao W; Cai K; Liang XJ
    Nanoscale; 2012 Oct; 4(20):6135-49. PubMed ID: 22929990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and functionalization of nanomaterials for therapeutic drug delivery.
    Grandhi TS; Rege K
    Adv Exp Med Biol; 2014; 811():157-82. PubMed ID: 24683032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Gastroenterological Association future trends committee report: the application of genomic and proteomic technologies to digestive disease diagnosis and treatment and their likely impact on gastroenterology clinical practice.
    Lazaridis KN; Juran BD;
    Gastroenterology; 2005 Nov; 129(5):1720-52. PubMed ID: 16285969
    [No Abstract]   [Full Text] [Related]  

  • 28. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The past 10 years of gastroenterology and hepatology-reflections and predictions.
    Friedman SL; Quigley EM; Sharkey KA; Sung JJ; Whitcomb DC
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):692-700. PubMed ID: 25291429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Self-ordered nanopore and nanotube platforms for drug delivery applications.
    Losic D; Simovic S
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1363-81. PubMed ID: 19860534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomedical nanotechnology for cancer.
    Pope-Harman A; Cheng MM; Robertson F; Sakamoto J; Ferrari M
    Med Clin North Am; 2007 Sep; 91(5):899-927. PubMed ID: 17826110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical applications of nanotechnology.
    Zdrojewicz Z; Waracki M; Bugaj B; Pypno D; Cabała K
    Postepy Hig Med Dosw (Online); 2015 Oct; 69():1196-204. PubMed ID: 26561846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives and potential applications of nanomedicine in breast and prostate cancer.
    Liu Y; Solomon M; Achilefu S
    Med Res Rev; 2013 Jan; 33(1):3-32. PubMed ID: 23239045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical gastroenterology--luxury or standard of service in gastroenterology?].
    Birkner B
    Z Gastroenterol; 2005 Dec; 43(12):1285-92. PubMed ID: 16315123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanotheranostics for personalized medicine.
    Mura S; Couvreur P
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1394-416. PubMed ID: 22728642
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular therapy in gastroenterology and hepatology].
    Wedemeyer J; Malek NP; Manns MP; Bahr MJ
    Internist (Berl); 2005 Aug; 46(8):861-2, 864-8, 870-2. PubMed ID: 15997383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications.
    Figuerola A; Di Corato R; Manna L; Pellegrino T
    Pharmacol Res; 2010 Aug; 62(2):126-43. PubMed ID: 20044004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.